Phase I Study of Dystrophin Plasmid-Based Gene Therapy in Duchenne/Becker Muscular Dystrophy-Reference-Cited by-同舟云学术

Phase I Study of Dystrophin Plasmid-Based Gene Therapy in Duchenne/Becker Muscular Dystrophy

Published:2004-11 Issue:11 Volume:15 Page:1065-1076
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Romero Norma B.¹,Braun Serge²,Benveniste Olivier³,Leturcq France⁴,Hogrel Jean-Yves¹,Morris Glenn E.⁵,Barois Annie⁶,Eymard Bruno¹,Payan Christine¹,Ortega Véronique¹,Boch Anne-Laure⁷,Lejean Lise⁸,Thioudellet Christine²,Mourot Brigitte²,Escot Christophe²,Choquel Aurore³,Recan Dominique⁴,Kaplan Jean-Claude⁴,Dickson George⁹,Klatzmann David¹⁰,Molinier-Frenckel Valérie¹¹,Guillet Jean-Gérard¹¹,Squiban Patrick²,Herson Serge³,Fardeau Michel¹

Affiliation:

1. Institut de Myologie, INSERM U582, CHU Pitié-Salpêtrière, 75013 Paris, France.

2. Transgene, 67082 Strasbourg, France.

3. Clinical Medicine Department, CHU Pitié-Salpêtrière, 75013 Paris, France.

4. Institut Cochin and Laboratory of Molecular Genetics, Cochin Hospital, 75014 Paris, France.

5. MRIC Biochemistry Group, NE Wales Institute, Wrexham LL11 2AW, United Kingdom.

6. Hôpital Raymond Poincaré, 92380 Garches, France.

7. Neurosurgery Department, CHU Pitié-Salpêtrière, 75013 Paris, France.

8. Anesthesiology Department, CHU Pitié-Salpêtrière, 75013 Paris, France.

9. Royal Holloway-University of London, Egham TW20 0EX, United Kingdom.

10. Immunology Department, CNRS UMR 7087, CHU Pitié-Salpêtrière, 75013 Paris, France.

11. Immunology Department, INSERM U567, Institut Cochin, 75014 Paris, France.